Evidence map›Paper›PMID 28949981›Full record

ArticlePloS one2017

Mycobacterium tuberculosis reactivates latent HIV-1 in T cells in vitro.

Erica C Larson, Camille L Novis, Laura J Martins, Amanda B Macedo, Kadyn E Kimball, Alberto Bosque, Vicente Planelles, Louis R Barrows

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. La Tunisie medicale · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Generation of Liposomes to Study the Effect ofInternational journal of molecular sciences · 2021
    Article
  9. A Role of Intracellular Toll-Like Receptors (3, 7, and 9) in Response toInternational journal of molecular sciences · 2020
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Erica C LarsonDepartment of Pharmacology and Toxicology, University of Utah, Salt Lake City, Utah, United States of America.ORCID http://orcid.org/0000-0001-5025-9369
Camille L NovisDepartment of Pathology, University of Utah, Salt Lake City, Utah, United States of America.
Laura J MartinsDepartment of Pathology, University of Utah, Salt Lake City, Utah, United States of America.ORCID http://orcid.org/0000-0001-8535-5350
Amanda B MacedoDepartment of Pathology, University of Utah, Salt Lake City, Utah, United States of America.
Kadyn E KimballDepartment of Pathology, University of Utah, Salt Lake City, Utah, United States of America.ORCID http://orcid.org/0000-0002-2813-8330
Alberto BosqueDepartment of Pathology, University of Utah, Salt Lake City, Utah, United States of America.ORCID http://orcid.org/0000-0002-8800-2160
Vicente PlanellesDepartment of Pathology, University of Utah, Salt Lake City, Utah, United States of America.
Louis R BarrowsDepartment of Pharmacology and Toxicology, University of Utah, Salt Lake City, Utah, United States of America.ORCID http://orcid.org/0000-0002-4200-6051
University of Utah · US

Funding

UTAH REGIONAL CANCER CENTERP30CA042014 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Jared P Rutter · 1986 to 2026
$72.6M
Developing Pathogen Recognition Receptor Agonists as Latency Reversing AgentsR01AI124722 · NIAID · UNIVERSITY OF UTAH · PI BOSQUE, ALBERTO · 2016 to 2020
$2.1M
Discovery and Characterization of Latency-Reversing CompoundsR21AI124823 · NIAID · UNIVERSITY OF UTAH · PI BARROWS, LOUIS R, PLANELLES, VICENTE · 2016 to 2017
$416k
NCI NIH HHS P30 CA042014NIAID NIH HHS R01 AI124722NIAID NIH HHS R21 AI124823
6 · The paper itself

Abstract

Following proviral integration into the host cell genome and establishment of a latent state, the human immunodeficiency virus type 1 (HIV-1) can reenter a productive life cycle in response to various stimuli. HIV-1 reactivation occurs when transcription factors, such as nuclear factor-κB (NF-κB), nuclear factor of activated T cells (NFAT), and activator protein -1 (AP-1), bind cognate sites within the long terminal repeat (LTR) region of the HIV-1 provirus to promote transcription. Interestingly, pattern recognition receptors (PRRs) that recognize pathogen-associated molecular patterns (PAMPs) can reactivate latent HIV-1 through activation of the transcription factor NF-κB. Some PRRs are expressed on central memory CD4+ T cells (TCM), which in HIV-1 patients constitute the main reservoir of latent HIV-1. Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), interacts with PRRs through membrane components. However, the ability of Mtb to reactivate latent HIV-1 has not been extensively studied. Here we show that phosphatidylinositol mannoside 6 (PIM6), a component of the Mtb membrane, in addition to whole bacteria in co-culture, can reactivate HIV-1 in a primary TCM cell model of latency. Using a JLAT model of HIV-1 latency, we found this interaction to be mediated through Toll-like receptor-2 (TLR-2). Thus, we describe a mechanism by which Mtb can exacerbate HIV-1 infection. We hypothesize that chronic Mtb infection can drive HIV-1 reactivation. The phenomenon described here could explain, in part, the poor prognosis that characterizes HIV-1/Mtb co-infection.

Indexed as

HIV-1HumansIn Vitro TechniquesMycobacterium tuberculosisT-LymphocytesVirus Latency

Identifiers

PMID28949981
PMCPMC5614573
OpenAlexW2759888013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.